Clinical Trial

A Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetics of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subjects

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This study is a single-dose, randomized, open-label, three-sequence, three-period crossover clinical trial to evaluate the effect of high-fat and low-fat meals on the pharmacokinetics of ammoxetine hydrochloride enteric-coated tablets in healthy subjects.
Trial Details
NCT Number NCT07508462
Lead Sponsor CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Conditions Healthy Participants
Enrollment 18 participants
Start Date 2024-05-30
Primary Completion 2024-06-17 (estimated)
Study Completion 2024-08-02 (estimated)
Updated on ClinicalTrials.gov 2026-04-02